PATENT CLAIM ANALYSIS

Application Number: 15937622
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2019-10
Patent Classification: ["424", "227100"]

Abstract:
In the invention described here, the approach is to formulate an edible vaccine based on N-terminal yeast surface display expression platform that producing  S.cerevisiae  EBY100/pYD5-preS2/S(adw) and  S.cerevisiae  EBY100/pYD5-preS2/S(adr) for protecting and treating human against hepatitis B virus (HBV) infection, suggesting that yeast surface display expression system expressing HBsAg antigen has potential as a prophylactic treatment for HBV in human via oral vaccination. The technology developed in this patent application can also be used to produce edible (oral) vaccines for preventing and treating other infectious diseases in human.

Claim (Index 2):
A composition as claimed in  claim 1 , wherein recombinant yeast display system that includes SEQ. ID NO.: 1\u2014 S.cerevisiae  EBY100/pYD5-preS2/S(adw) and SEQ. ID. NO.: 2\u2014 S.cerevisiae  EBY100/pYD5-preS2/S(adr).

Metadata:
- Claim Count in Document: 7.0
- Percentile: 90.0
- Lexical Diversity: 1.40278
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15648863', '12225341', '12209093', '12526759', '10677074']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6924539527142609
- 35 USC 102 Novelty (BERT): 0.5040812747090383
- Combined Prediction Score: 0.6736166849137387
- Mean Citation Score: 209.411502
- Max Citation Score: 274.09167
- Similarity Product: 239.98498928239704

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test